From Medscape Dermatology

Coverage from the

26th European Academy of Dermatology and Venereology (EADV) Congress

September 13 - 17, 2017; Geneva, Switzerland

September 13 - 17, 2017 Geneva, Switzerland

EADV For Irritating Itch, a Promising Option Under Scrutiny Investigational serlopitant afforded clinical trial patients quick relief for a variety of pruritis-characterized diseases.
Medscape Medical News, September 15, 2017
EADV Immunotherapies Center Stage at EADV The designated hot topic of this year's European Academy of Dermatology and Venereology (EADV) Congress will have specialists talking about the latest developments in immunotherapies.
Medscape Medical News, September 7, 2017

Conference News

EADV IL-23 Blocker for Psoriasis Successful in Extension Trials
Medscape Medical News, September 19, 2017
EADV Skin-Directed Tactics Optimal for Early Cutaneous Lymphoma
Medscape Medical News, September 18, 2017
EADV 'Follow the Money' in Extreme Skin Cancer Care
Medscape Medical News, September 17, 2017

EADV For Irritating Itch, a Promising Option Under Scrutiny
Medscape Medical News, September 15, 2017
EADV Immunotherapies Center Stage at EADV
Medscape Medical News, September 7, 2017

Popular News From the 25th EADV Congress

Head-to-Head Results Compare Biologics for Psoriasis For patients with moderate to severe plaque psoriasis, ixekizumab is more effective than ustekinumab at 12 weeks, researchers report, but a longer-term study is needed to confirm this.
Medscape Medical News, Oct 5, 2016
Dupilumab Promising for Atopic Dermatitis in Phase 3 Studies The biologic significantly improved symptoms of atopic dermatitis compared with placebo. Researchers also looked at the effect of treatment on quality of life.
Medscape Medical News, Oct 1, 2016
Ixekizumab Improves Palmoplantar Psoriasis Within 2 Weeks For patients with moderate to severe palmoplantar psoriasis, response to the monoclonal antibody ixekizumab is quick, and the efficacy persisted out to 60 weeks, according to investigators.
Medscape Medical News, Sep 30, 2016

Medscape Dermatology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Previous Coverage